Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

CDXS

Codexis (CDXS)

Codexis Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CDXS
FechaHoraFuenteTítuloSímboloCompañía
14/05/202408:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CDXSCodexis Inc
14/05/202405:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
14/05/202405:00GlobeNewswire Inc.Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual MeetingNASDAQ:CDXSCodexis Inc
02/05/202415:05GlobeNewswire Inc.Codexis Reports First Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
18/04/202415:05GlobeNewswire Inc.Codexis to Report First Quarter 2024 Financial Results on May 2NASDAQ:CDXSCodexis Inc
11/04/202406:05GlobeNewswire Inc.Codexis Appoints Carole Cobb, MBA, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
28/02/202415:05GlobeNewswire Inc.Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:CDXSCodexis Inc
27/02/202411:15AllPennyStocks.comBiotech Rallied Strongly On Exclusive Licensing AgreementNASDAQ:CDXSCodexis Inc
26/02/202415:05GlobeNewswire Inc.Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheNASDAQ:CDXSCodexis Inc
26/02/202407:05GlobeNewswire Inc.Codexis to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:CDXSCodexis Inc
20/02/202407:05GlobeNewswire Inc.Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
14/02/202415:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
14/02/202415:05GlobeNewswire Inc.Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28NASDAQ:CDXSCodexis Inc
13/02/202415:05GlobeNewswire Inc.Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key MilestonesNASDAQ:CDXSCodexis Inc
01/02/202415:05GlobeNewswire Inc.seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General MeetingNASDAQ:CDXSCodexis Inc
02/01/202420:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
27/12/202307:30GlobeNewswire Inc.Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108NASDAQ:CDXSCodexis Inc
13/12/202315:06GlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNASDAQ:CDXSCodexis Inc
13/12/202315:05GlobeNewswire Inc.Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ PlatformNASDAQ:CDXSCodexis Inc
11/12/202306:05GlobeNewswire Inc.Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics ManufacturingNASDAQ:CDXSCodexis Inc
28/11/202315:05GlobeNewswire Inc.Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023NASDAQ:CDXSCodexis Inc
15/11/202316:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CDXSCodexis Inc
14/11/202315:05GlobeNewswire Inc.Codexis to Participate in 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:CDXSCodexis Inc
03/11/202315:26Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CDXSCodexis Inc
03/11/202315:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDXSCodexis Inc
02/11/202315:05GlobeNewswire Inc.Codexis Reports Third Quarter 2023 Financial ResultsNASDAQ:CDXSCodexis Inc
31/10/202315:05GlobeNewswire Inc.Codexis to Participate in Upcoming Healthcare ConferencesNASDAQ:CDXSCodexis Inc
27/10/202314:35GlobeNewswire Inc.Codexis to Present Update on ECO Synthesis™ Platform at TIDES EuropeNASDAQ:CDXSCodexis Inc
19/10/202315:05GlobeNewswire Inc.Codexis to Report Third Quarter 2023 Financial Results on November 2NASDAQ:CDXSCodexis Inc
29/09/202306:05GlobeNewswire Inc.Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton AwardNASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS